Union Budget 2021 India: “The continuing modest allocation towards the healthcare sector would make it challenging for the government to meet its target of public sector healthcare investment of 2.5% of the GDP by 2025,”
Bharat Biotech (BB) founder and chairman Dr Krishna Ella, on Monday, said that the approval for BB’s Covaxin was being dragged into a political controversy and that it was within the rules laid down by the government in 201
The way to test the entire country is to do the kind of antibody tests or sero-surveys that ICMR did last month regularly to see which parts of the country are more likely to have a higher disease burden.
CDDEP-Princeton-Johns Hopkins researchers estimate a mammoth hospitalisation problem from COVID-19 in India. Pushing out the peak,i.e. delaying its occurrence through lockdowns, seems the only workable strategy till a vaccine
A study by two India-origin researchers at the University of Cambridge, is based on the SIR approach, but takes into account age and social contact structure to assess the impact of the lockdown and social distancing measures
Lopinavir/Ritonavir, a fixed dose combination antiretroviral sold under the brand name of Kaletra, has been approved by the Central Drugs Standard Control Organization (CDSCO), for restricted public health use among the sympt